Identification of a Small-Molecule Entry Inhibitor for Filoviruses

Ebola virus (EBOV) causes severe hemorrhagic fever, for which therapeutic options are not available. Preventing the entry of EBOV into host cells is an attractive antiviral strategy, which has been validated for HIV by the FDA approval of the anti-HIV drug enfuvirtide. To identify inhibitors of EBOV...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Basu, Arnab, Li, Bing, Mills, Debra M., Panchal, Rekha G., Cardinale, Steven C., Butler, Michelle M., Peet, Norton P., Majgier-Baranowska, Helena, Williams, John D., Patel, Ishan, Moir, Donald T., Bavari, Sina, Ray, Ranjit, Farzan, Michael R., Rong, Lijun, Bowlin, Terry L.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Microbiology (ASM) 2011
Θέματα:
Vaccines and Antiviral Agents
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3067866/
https://ncbi.nlm.nih.gov/pubmed/21270170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01456-10
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια